US Biologic Presents Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics

Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, presented key findings on a chewable flu vaccine that US Biologic is developing in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) as part of its Beyond the Needle program. The presentation was held at the…

Read More

US Biologic – A Breakthrough: Edible Vaccine in “Gummy” Form

City Current

Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they…

Read More

US Biologic Presents at World Vaccine Congress

US Biologic’s CSO, Dr. Jolieke G. van Oosterwijk, presented at the World Vaccine Congress in Washington, D.C. Dr. van Oosterwijk discussed “using zoonotic disease surveillance to guide oral vaccine design” and presented the methods US Biologic uses to prevent pandemic-level diseases. In her talk, Dr. van Oosterwijk explained to the audience the unique nature of oral…

Read More

An Invasive New Tick Is Spreading in the U.S.

“For the first time in 50 years, a new tick species has arrived in the United States — one that in its Asian home range carries fearsome diseases. The Asian long-horned tick, Haemaphysalis longicornis, is spreading rapidly along the Eastern Seaboard. It has been found in seven states and in the heavily populated suburbs of…

Read More

Zoonotic Implications of Changing Tick Populations

“Practitioners in both veterinary and human medicine must remain aware of the changing geography of ticks and associated vector-borne diseases. The discovery of the Asian tick H longicornis in New Jersey and Virginia should be an important reminder of the fact that ‘ticks and tickborne pathogens do not recognize international boundaries.’ Thus, ‘a robust international disease monitoring network’…

Read More